Previous Close | 0.8020 |
Open | 0.8000 |
Bid | 0.8420 x N/A |
Ask | 0.9060 x N/A |
Day's Range | 0.8000 - 0.8060 |
52 Week Range | 0.5060 - 1.9250 |
Volume | |
Avg. Volume | 11 |
Market Cap | 40.084M |
Beta (5Y Monthly) | 1.68 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
MustGrow has received The State of Oregon Agriculture approval to commence sales of TerraSanteTM, an organic biofertility product, in Oregon State.MustGrow's recently-awarded organic compliance certification from the USDA National Organic Program (OMRI Listed®) will apply to this Registration.Mustard-derived TerraSanteTM focuses on soil microbiome health, nutrient/water use efficiencies, and plant yields.Saskatoon, Saskatchewan--(Newsfile Corp. - February 6, 2024) - MustGrow Biologics Corp. (TSX
Saskatoon, Saskatchewan--(Newsfile Corp. - December 13, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) ("MustGrow") wishes to provide additional information about the collaboration agreement (the "Agreement") with Bayer AG ("Bayer") which was announced December 11, 2023. The Agreement is a license and collaboration agreement enabling Bayer to further evaluate certain soil applications of MustGrow's mustard-based biocontrol technologies and to develop, formulate and comme
MustGrow Biologics CEO Corey Giasson joined Steve Darling from Proactive to share news the company has signed a collaboration agreement with Bayer AG that focuses on the soil applications of MustGr...